Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass

NCT01410617 is registered in ClinicalTrials.gov with Imam Khomeini Hospital as lead sponsor.

NCT NCT01410617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01410617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass
Lead sponsor
Imam Khomeini Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2011
Completion date
December 31, 2013
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage3, chronic kidney disease stage4, coronary artery disease